The SCF complex plays a crucial role in:
SCF complex, acronym for SKP1-CUL1-F-box protein, represents prototypical cullin-RING ubiquitin ligase family controlling G1/S transition through regulated proteolysis of CDK inhibitors. Core scaffold comprises elongated Cullin1 linking adaptor SKP1 and RING domain protein Rbx1 that recruits E2 ubiquitin-conjugating enzyme. Substrate specificity arises from interchangeable F-box proteins containing leucine-rich repeats or WD40 domains that bind phosphorylated degrons. In budding yeast, F-box Cdc4 recognizes Sic1 inhibitor after phosphorylation by Cln-CDK1 at multiple CDK consensus sites, while mammalian Skp2 with cofactor Cks1 recognizes p27Kip1 phosphorylated at Thr187 by cyclin E-CDK2 following mitogen signaling. SCF-catalyzed K48 polyubiquitination directs Sic1 and p27 to 26S proteasome, relieving inhibition of S-phase CDKs. This degradation derepresses cyclin E-CDK2 mediated Rb phosphorylation and origin firing, initiating DNA synthesis. Feedback loop where CDK activity promotes inhibitor destruction creates bistable switch ensuring irreversible S entry. Overexpression of Skp2 in cancers prematurely lowers p27, accelerating proliferation. This circuitry is highly conserved across eukaryotes, integrating growth factor signals, DNA damage surveillance, and developmental cues, and its disruption frequently underlies oncogenesis, providing targets for checkpoint inhibitors and cancer therapeutics.
Ref: Morgan, The Cell Cycle: Principles of Control, 2nd ed., Chapter 5: SCF Ligases and CDK Inhibitors.